ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2026)

ARS Pharmaceuticals has disclosed Inventory Average across 3 years of filings, most recently posting $8.6 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $8.6 million, up 37.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.6 million (up 37.69% YoY), and the FY2025 annual result was $6.8 million, changed N/A from the prior year.
• Inventory Average came in at $8.6 million for Q1 2026 at ARS Pharmaceuticals, up from $8.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.6 million in Q1 2026 to a low of $3.0 million in Q4 2024.
• The 3-year median for Inventory Average is $8.0 million (2025), against an average of $7.0 million.
• Across the five-year window, Inventory Average soared 172.5% in 2025 and soared 37.69% in 2026, its largest moves.
• ARS Pharmaceuticals' Inventory Average stood at $3.0 million in 2024, then soared by 172.5% to $8.1 million in 2025, then climbed by 6.41% to $8.6 million in 2026.
• The last three Inventory Average figures came in at $8.6 million (Q1 2026), $8.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.